Increasing access to drugs and R&D in the pharmaceutical industry is expected to boost growth of the global life sciences market over the forecast period. For instance, in 2018, The Center for Drug Evaluation and Research (CDER) – a division of the U.S. Food and Drug Administration (FDA) approved 59 novel drugs compared to 46 in 2017.
Increasing R&D in gene and cell therapies is also expected to propel growth of the global life sciences market. For instance, in 2017, Luxurna, the first human gene therapy drug for an inherited retinal dystrophy, was approved by the U.S. FDA. Kymriah and Yeskarta, two cell-based gene therapies for the treatment of acute lymphoblastic leukemia (ALL) were also approved by the U.S. FDA in 2017.
However, uncertain trade policies is expected to hinder growth of the global life sciences market over the forecast period.
North America is expected to witness significant growth in the global life sciences market over the forecast period. This is attributed increasing presence of life sciences companies and major life science institutes in the U.S. For instance, the Palm Beach County in Florida U.S. is home to over 700 life sciences companies and Max Planck Institute and The Scripps Research Institute. Moreover, increasing investment in the life sciences sector is also expected to boost growth of the market in North America. For instance, in a life sciences Series A investments in Florida for 2018-19, Expansion Therapeutics and X-Vax raised a total of US$ 110 million.
Key players in the global life sciences market are focused on facility expansion to enhance their market share. For instance, in February 2019, Beacon Pharmaceutical, a early-stage life sciences firm, announced plans to construct a state-of-the-art life sciences accelerator and biologics synthesis facility at a relocated facility in Florida, U.S.
Key players in the market are also focused on adopting M&A strategies to expand their product portfolio. For instance, February 2019, F. Hoffmann-La Roche Ltd. and Spark Therapeutics, Inc. announced entering into a definitive merger agreement for Roche to fully acquire Spark Therapeutics at a price of US$ 114.50 per share in an all-cash transaction. Moreover, in October 2019, Belgium-based UCB announced plans to acquire Cambridge, Massachusetts-based Ra Pharmaceuticals for US$ 2.1 billion. Ra Pharmaceuticals owns zilucoplan, a late-stage asset targeting rare diseases such as generalized myasthenia gravis (gMG).
Key Takeaways
Table of Contents
Part I Life Sciences Industry Overview
Chapter One Life Sciences Industry Overview
1.1 Life Sciences Definition
1.2 Life Sciences Classification Analysis
1.2.1 Life Sciences Main Classification Analysis
1.2.2 Life Sciences Main Classification Share Analysis
1.3 Life Sciences Application Analysis
1.3.1 Life Sciences Main Application Analysis
1.3.2 Life Sciences Main Application Share Analysis
1.4 Life Sciences Industry Chain Structure Analysis
1.5 Life Sciences Industry Development Overview
1.5.1 Life Sciences Product History Development Overview
1.5.1 Life Sciences Product Market Development Overview
1.6 Life Sciences Global Market Comparison Analysis
1.6.1 Life Sciences Global Import Market Analysis
1.6.2 Life Sciences Global Export Market Analysis
1.6.3 Life Sciences Global Main Region Market Analysis
1.6.4 Life Sciences Global Market Comparison Analysis
1.6.5 Life Sciences Global Market Development Trend Analysis
Chapter Two Life Sciences Up and Down Stream Industry Analysis
2.1 Upstream Raw Materials Analysis
2.1.1 Proportion of Manufacturing Cost
2.1.2 Manufacturing Cost Structure of Life Sciences Analysis
2.2 Down Stream Market Analysis
2.2.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis
Part II Asia Life Sciences Industry (The Report Company Including the Below Listed But Not All)
Chapter Three Asia Life Sciences Market Analysis
3.1 Asia Life Sciences Product Development History
3.2 Asia Life Sciences Competitive Landscape Analysis
3.3 Asia Life Sciences Market Development Trend
Chapter Four 2014-2019 Asia Life Sciences Productions Supply Sales Demand Market Status and Forecast
4.1 2014-2019 Life Sciences Production Overview
4.2 2014-2019 Life Sciences Production Market Share Analysis
4.3 2014-2019 Life Sciences Demand Overview
4.4 2014-2019 Life Sciences Supply Demand and Shortage
4.5 2014-2019 Life Sciences Import Export Consumption
4.6 2014-2019 Life Sciences Cost Price Production Value Gross Margin
Chapter Five Asia Life Sciences Key Manufacturers Analysis
5.1 Company A
5.1.1 Company Profile
5.1.2 Product Picture and Specification
5.1.3 Product Application Analysis
5.1.4 Capacity Production Price Cost Production Value
5.1.5 Contact Information
5.2 Company B
5.2.1 Company Profile
5.2.2 Product Picture and Specification
5.2.3 Product Application Analysis
5.2.4 Capacity Production Price Cost Production Value
5.2.5 Contact Information
5.3 Company C
5.3.1 Company Profile
5.3.2 Product Picture and Specification
5.3.3 Product Application Analysis
5.3.4 Capacity Production Price Cost Production Value
5.3.5 Contact Information
5.4 Company D
5.4.1 Company Profile
5.4.2 Product Picture and Specification
5.4.3 Product Application Analysis
5.4.4 Capacity Production Price Cost Production Value
5.4.5 Contact Information
…
…
Chapter Six Asia Life Sciences Industry Development Trend
6.1 2019-2023 Life Sciences Production Overview
6.2 2019-2023 Life Sciences Production Market Share Analysis
6.3 2019-2023 Life Sciences Demand Overview
6.4 2019-2023 Life Sciences Supply Demand and Shortage
6.5 2019-2023 Life Sciences Import Export Consumption
6.6 2019-2023 Life Sciences Cost Price Production Value Gross Margin
Part III North American Life Sciences Industry (The Report Company Including the Below Listed But Not All)
Chapter Seven North American Life Sciences Market Analysis
7.1 North American Life Sciences Product Development History
7.2 North American Life Sciences Competitive Landscape Analysis
7.3 North American Life Sciences Market Development Trend
Chapter Eight 2014-2019 North American Life Sciences Productions Supply Sales Demand Market Status and Forecast
8.1 2014-2019 Life Sciences Production Overview
8.2 2014-2019 Life Sciences Production Market Share Analysis
8.3 2014-2019 Life Sciences Demand Overview
8.4 2014-2019 Life Sciences Supply Demand and Shortage
8.5 2014-2019 Life Sciences Import Export Consumption
8.6 2014-2019 Life Sciences Cost Price Production Value Gross Margin
Chapter Nine North American Life Sciences Key Manufacturers Analysis
9.1 Company A
9.1.1 Company Profile
9.1.2 Product Picture and Specification
9.1.3 Product Application Analysis
9.1.4 Capacity Production Price Cost Production Value
9.1.5 Contact Information
9.2 Company B
9.2.1 Company Profile
9.2.2 Product Picture and Specification
9.2.3 Product Application Analysis
9.2.4 Capacity Production Price Cost Production Value
9.2.5 Contact Information
…
…
Chapter Ten North American Life Sciences Industry Development Trend
10.1 2019-2023 Life Sciences Production Overview
10.2 2019-2023 Life Sciences Production Market Share Analysis
10.3 2019-2023 Life Sciences Demand Overview
10.4 2019-2023 Life Sciences Supply Demand and Shortage
10.5 2019-2023 Life Sciences Import Export Consumption
10.6 2019-2023 Life Sciences Cost Price Production Value Gross Margin
Part IV Europe Life Sciences Industry Analysis (The Report Company Including the Below Listed But Not All)
Chapter Eleven Europe Life Sciences Market Analysis
11.1 Europe Life Sciences Product Development History
11.2 Europe Life Sciences Competitive Landscape Analysis
11.3 Europe Life Sciences Market Development Trend
Chapter Twelve 2014-2019 Europe Life Sciences Productions Supply Sales Demand Market Status and Forecast
12.1 2014-2019 Life Sciences Production Overview
12.2 2014-2019 Life Sciences Production Market Share Analysis
12.3 2014-2019 Life Sciences Demand Overview
12.4 2014-2019 Life Sciences Supply Demand and Shortage
12.5 2014-2019 Life Sciences Import Export Consumption
12.6 2014-2019 Life Sciences Cost Price Production Value Gross Margin
Chapter Thirteen Europe Life Sciences Key Manufacturers Analysis
13.1 Company A
13.1.1 Company Profile
13.1.2 Product Picture and Specification
13.1.3 Product Application Analysis
13.1.4 Capacity Production Price Cost Production Value
13.1.5 Contact Information
13.2 Company B
13.2.1 Company Profile
13.2.2 Product Picture and Specification
13.2.3 Product Application Analysis
13.2.4 Capacity Production Price Cost Production Value
13.2.5 Contact Information
…
…
Chapter Fourteen Europe Life Sciences Industry Development Trend
14.1 2019-2023 Life Sciences Production Overview
14.2 2019-2023 Life Sciences Production Market Share Analysis
14.3 2019-2023 Life Sciences Demand Overview
14.4 2019-2023 Life Sciences Supply Demand and Shortage
14.5 2019-2023 Life Sciences Import Export Consumption
14.6 2019-2023 Life Sciences Cost Price Production Value Gross Margin
Part V Life Sciences Marketing Channels and Investment Feasibility
Chapter Fifteen Life Sciences Marketing Channels Development Proposals Analysis
15.1 Life Sciences Marketing Channels Status
15.2 Life Sciences Marketing Channels Characteristic
15.3 Life Sciences Marketing Channels Development Trend
15.2 New Firms Enter Market Strategy
15.3 New Project Investment Proposals
Chapter Sixteen Development Environmental Analysis
16.1 China Macroeconomic Environment Analysis
16.2 European Economic Environmental Analysis
16.3 United States Economic Environmental Analysis
16.4 Japan Economic Environmental Analysis
16.5 Global Economic Environmental Analysis
Chapter Seventeen Life Sciences New Project Investment Feasibility Analysis
17.1 Life Sciences Market Analysis
17.2 Life Sciences Project SWOT Analysis
17.3 Life Sciences New Project Investment Feasibility Analysis
Part VI Global Life Sciences Industry Conclusions
Chapter Eighteen 2014-2019 Global Life Sciences Productions Supply Sales Demand Market Status and Forecast
18.1 2014-2019 Life Sciences Production Overview
18.2 2014-2019 Life Sciences Production Market Share Analysis
18.3 2014-2019 Life Sciences Demand Overview
18.4 2014-2019 Life Sciences Supply Demand and Shortage
18.5 2014-2019 Life Sciences Import Export Consumption
18.6 2014-2019 Life Sciences Cost Price Production Value Gross Margin
Chapter Nineteen Global Life Sciences Industry Development Trend
19.1 2019-2023 Life Sciences Production Overview
19.2 2019-2023 Life Sciences Production Market Share Analysis
19.3 2019-2023 Life Sciences Demand Overview
19.4 2019-2023 Life Sciences Supply Demand and Shortage
19.5 2019-2023 Life Sciences Import Export Consumption
19.6 2019-2023 Life Sciences Cost Price Production Value Gross Margin
Chapter Twenty Global Life Sciences Industry Research Conclusions
| Price : US$ 3500 | Date : Apr 2024 |
| Category : Manufacturing and Construction | Pages : 154 |
| Price : US$ 3500 | Date : Apr 2024 |
| Category : Electronics | Pages : 122 |
| Price : US$ 3500 | Date : Feb 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 146 |
| Price : US$ 3500 | Date : Feb 2024 |
| Category : Consumer Goods and Retail | Pages : 129 |
| Price : US$ 3500 | Date : Feb 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 100 |
We will be happy to help you find what you need. Please call us or write to us:
Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).
This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection
Request Sample 
Request Discount 
Inquire Before Buy
